Nuwellis (NUWE) Cash from Financing Activities (2011 - 2026)
Nuwellis (NUWE) posted Cash from Financing Activities of $4.4 million for Q1 2026, up 317.78% on a QoQ basis from $1.1 million in Q4 2025.
Nuwellis (NUWE) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Nuwellis' Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (up 8.34% YoY) and the FY2025 annual result came in at $6.9 million, down 36.69% from the prior year.
- Cash from Financing Activities was $4.4 million for Q1 2026 at Nuwellis, up from $1.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $9.5 million in Q4 2022 and bottomed at -$20000.0 in Q3 2023.
- A 5-year average of $2.2 million and a median of $1.7 million in 2023 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 189120.0% in 2022, while the deepest fall reached 100.17% in 2022.
- Nuwellis' Cash from Financing Activities stood at $9.5 million in 2022, then slumped by 83.12% to $1.6 million in 2023, then surged by 195.67% to $4.7 million in 2024, then slumped by 77.69% to $1.1 million in 2025, then soared by 317.78% to $4.4 million in 2026.
- Business Quant data shows NUWE's Cash from Financing Activities at $4.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.40 Mn |
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |